KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Non-cash Items (2017 - 2018)

Alnylam Pharmaceuticals' Non-cash Items history spans 8 years, with the latest figure at $1.4 million for Q4 2018.

  • For Q4 2018, Non-cash Items rose 74.66% year-over-year to $1.4 million; the TTM value through Dec 2018 reached $1.4 million, up 74.66%, while the annual FY2018 figure was $1.4 million, 74.66% up from the prior year.
  • Non-cash Items reached $1.4 million in Q4 2018 per ALNY's latest filing, up from $813000.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $352.6 million in Q4 2015 to a low of $813000.0 in Q4 2017.
  • Average Non-cash Items over 4 years is $89.9 million, with a median of $3.1 million recorded in 2014.
  • Peak YoY movement for Non-cash Items: decreased 11.05% in 2014, then skyrocketed 7346.07% in 2015.
  • A 4-year view of Non-cash Items shows it stood at $4.7 million in 2014, then surged by 7346.07% to $352.6 million in 2015, then crashed by 99.77% to $813000.0 in 2017, then skyrocketed by 74.66% to $1.4 million in 2018.
  • Per Business Quant, the three most recent readings for ALNY's Non-cash Items are $1.4 million (Q4 2018), $813000.0 (Q4 2017), and $352.6 million (Q4 2015).